We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally. It offers oncology and non-oncology API's.; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is headquartered in Raichur, India.
TODAY'S HIGH
471
TODAY'S LOW
435.15
52 WEEK HIGH
670.4
52 WEEK LOW
380
% of Shares Held by
All Insider
68.12%
% of Shares Held by
Institutions
2.95%
% of Float Held by
Institutions
9.26%
Number of Institutions
Holding Shares
17
MARKET CAP
3931.69 Cr.
ETERPRISE VALUE
4355.70 Cr.
NO. OF SHARES
8.68 Cr.
BOOK VALUE
183.885
DIV. YIELD
1.1%
DEBT
835.37 Cr.
GROSS PROFIT
587.93 Cr.
CASH
36.77 Cr.
REVENUE
1013.46 Cr.
REVENUE/SHARE
123.194
| Particulars | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|
| Investments | 46.67 Cr. | -8.96 Cr. | 158.45 Cr. | 125.14 Cr. |
| Change To Liabilities | -6.30 Cr. | 5.40 Cr. | -20.54 Cr. | -2.62 Cr. |
| Total cashflows from Investing Activities | -404.27 Cr. | -289.51 Cr. | -196.16 Cr. | -8.76 Cr. |
| Net Borrowings | 458.24 Cr. | 193.45 Cr. | 2.97 Cr. | -51.47 Cr. |
| Total Cash from Financing Activities | 436.37 Cr. | 175.50 Cr. | 10.05 Cr. | -60.90 Cr. |
| Other Liabilities | -6.68 Cr. | 5.16 Cr. | 24.71 Cr. | -21.81 Cr. |
| Total Assets | 0 | 0 | 0 | 0 |
| Net Income | 147.78 Cr. | 156.15 Cr. | 112.26 Cr. | 105.24 Cr. |
| Change in Cash | 79.02 Cr. | 10.18 Cr. | -39.46 Cr. | -26.14 Cr. |
| Effect of Exchange Rate | -14.32 Lakhs | -17.87 Lakhs | -14.22 Lakhs | -1.40 Cr. |
| Total Cash from Operating Activities | 47.07 Cr. | 124.37 Cr. | 146.77 Cr. | 44.91 Cr. |
| Depreciation | 52.17 Cr. | 42.09 Cr. | 40.45 Cr. | 36.16 Cr. |
| Other Cashflows from Investing Activities | -39.07 Cr. | 63.99 Cr. | -57.22 Cr. | 3.51 Cr. |
| Dividends Paid | 0 | -20.63 Cr. | -20.63 Cr. | -7.23 Cr. |
| Change to Inventory | -106.34 Cr. | -41.16 Cr. | 1.03 Cr. | 1.28 Cr. |
| Change to Account Receivables | 13.04 Cr. | -32.56 Cr. | 13.51 Cr. | -46.51 Cr. |
| Other Cashflows from Financing Activities | -21.86 Cr. | 2.68 Cr. | 7.08 Cr. | -2.19 Cr. |
| Change to Net Income | -48.39 Cr. | -12.40 Cr. | -26.25 Cr. | -27.88 Cr. |
| Capital Expenditures | -354.24 Cr. | -349.27 Cr. | -299.97 Cr. | -137.97 Cr. |
| Particulars | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 195.05 Cr. | 188.05 Cr. | 135.67 Cr. | 136.76 Cr. |
| Minority Interest | -11.17 Cr. | -7.91 Cr. | -7.61 Cr. | -5.22 Cr. |
| Net Income | 118.76 Cr. | 172.31 Cr. | 112.75 Cr. | 114.75 Cr. |
| Selling General Administrative | 246.73 Cr. | 204.30 Cr. | 183.41 Cr. | 155.23 Cr. |
| Gross Profit | 587.93 Cr. | 600.12 Cr. | 448.19 Cr. | 412.86 Cr. |
| Ebit | 118.76 Cr. | 172.31 Cr. | 112.75 Cr. | 114.75 Cr. |
| Operating Income | 118.76 Cr. | 172.31 Cr. | 112.75 Cr. | 114.75 Cr. |
| Other Operating Expenses | 168.46 Cr. | 179.73 Cr. | 109.97 Cr. | 105.39 Cr. |
| Interest Expense | -21.86 Cr. | -4.55 Cr. | -3.67 Cr. | -2.66 Cr. |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | 48.84 Cr. | 33.49 Cr. | 26.17 Cr. | 33.90 Cr. |
| Total Revenue | 901.58 Cr. | 908.22 Cr. | 733.66 Cr. | 789.40 Cr. |
| Total Operating Expenses | 782.82 Cr. | 735.91 Cr. | 620.90 Cr. | 674.65 Cr. |
| Cost of Revenue | 313.64 Cr. | 308.10 Cr. | 285.46 Cr. | 376.53 Cr. |
| Total Other Income Expense Net | 76.29 Cr. | 15.73 Cr. | 22.92 Cr. | 22.01 Cr. |
| Discontinued Operations | None | None | None | None |
| Net Income from Continuous Ops. | 146.20 Cr. | 154.56 Cr. | 109.50 Cr. | 102.86 Cr. |
| Net Income Applicable to Common Shares | 147.78 Cr. | 156.15 Cr. | 112.26 Cr. | 105.24 Cr. |
| Particulars | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|
| Intangible Assets | 313.03 Cr. | 213.84 Cr. | 151.40 Cr. | 100.26 Cr. |
| Capital Surplus | 428.63 Cr. | 426.88 Cr. | 428.63 Cr. | 428.63 Cr. |
| Total Liabilities | 1170.05 Cr. | 667.75 Cr. | 420.05 Cr. | 419.32 Cr. |
| Stock Holder Equity | 1478.66 Cr. | 1329.36 Cr. | 1197.58 Cr. | 1085.03 Cr. |
| Minority Interest | -11.17 Cr. | -7.91 Cr. | -7.61 Cr. | -5.22 Cr. |
| Other Liabilities | 120.68 Cr. | 55.04 Cr. | 33.53 Cr. | 14.33 Cr. |
| Total Assets | 2637.55 Cr. | 1989.20 Cr. | 1610.02 Cr. | 1499.13 Cr. |
| Common Stock | 8.15 Cr. | 8.15 Cr. | 8.15 Cr. | 8.15 Cr. |
| Retained Earnings | 1043.33 Cr. | 894.82 Cr. | 759.31 Cr. | 647.04 Cr. |
| Other Liabilities | 85.55 Cr. | 89.82 Cr. | 85.52 Cr. | 85.36 Cr. |
| Good Will | 44.19 Cr. | 37 Cr. | 36.75 Cr. | 36.88 Cr. |
| Treasury Stock | -1.46 Cr. | -50.16 Lakhs | 1.48 Cr. | 1.19 Cr. |
| Other Assets | 46.45 Cr. | 38.20 Cr. | 75.58 Cr. | 62.66 Cr. |
| Cash | 122.84 Cr. | 44.31 Cr. | 34.27 Cr. | 73.64 Cr. |
| Current Liabilities | 602.16 Cr. | 410.81 Cr. | 253.44 Cr. | 265.84 Cr. |
| Long Term Asset Charges | 0 | 0 | 0 | 0 |
| Short Long Term Debt | 120.21 Cr. | 59.58 Cr. | 26.36 Cr. | 24.83 Cr. |
| Other Stockholder Equity | -1.46 Cr. | -50.16 Lakhs | 1.48 Cr. | 1.19 Cr. |
| Property Plant Equipment | 1294.59 Cr. | 1065.84 Cr. | 798.96 Cr. | 606.88 Cr. |
| Total Cur. Assets | 918.05 Cr. | 623.85 Cr. | 545.05 Cr. | 671.97 Cr. |
| Long Term Investments | 21.21 Cr. | 10.45 Cr. | 2.25 Cr. | 20.45 Cr. |
| Net Tangible Assets | 1121.43 Cr. | 1078.51 Cr. | 1009.42 Cr. | 947.87 Cr. |
| Short Term Investments | 0 | 0 | 12 k | 119.54 Cr. |
| Net Receivables | 323.88 Cr. | 320.66 Cr. | 245.59 Cr. | 252.17 Cr. |
| Long Term Debt | 480.47 Cr. | 165.01 Cr. | 81.09 Cr. | 68.11 Cr. |
| Inventory | 316.83 Cr. | 226.43 Cr. | 187.66 Cr. | 188.70 Cr. |
| Accounts Payable | 72.14 Cr. | 92.54 Cr. | 80.72 Cr. | 103.73 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account